ERDOĞAN, A. And ÖZKAN, A. 2019. Cetuximab and epirubicin HCl-combined application as a possibility to treat both parental and epirubicin HCl-resistant liver cancer cells. BIOLOGIA FUTURA , vol.70, no.3 , 175-184.

ERDOĞAN, A., & ÖZKAN, A., (2019). Cetuximab and epirubicin HCl-combined application as a possibility to treat both parental and epirubicin HCl-resistant liver cancer cells. BIOLOGIA FUTURA , vol.70, no.3, 175-184.

ERDOĞAN, AYŞE, And AYSUN ÖZKAN. "Cetuximab and epirubicin HCl-combined application as a possibility to treat both parental and epirubicin HCl-resistant liver cancer cells," BIOLOGIA FUTURA , vol.70, no.3, 175-184, 2019

ERDOĞAN, AYŞE And ÖZKAN, AYSUN. "Cetuximab and epirubicin HCl-combined application as a possibility to treat both parental and epirubicin HCl-resistant liver cancer cells." BIOLOGIA FUTURA , vol.70, no.3, pp.175-184, 2019

ERDOĞAN, A. And ÖZKAN, A. (2019) . "Cetuximab and epirubicin HCl-combined application as a possibility to treat both parental and epirubicin HCl-resistant liver cancer cells." BIOLOGIA FUTURA , vol.70, no.3, pp.175-184.

@article{article, author={AYŞE ERDOĞAN And author={AYSUN ÖZKAN}, title={Cetuximab and epirubicin HCl-combined application as a possibility to treat both parental and epirubicin HCl-resistant liver cancer cells}, journal={BIOLOGIA FUTURA}, year=2019, pages={175-184} }